The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

29 Jan 2019 12:45

RNS Number : 4297O
Pennant International Group PLC
29 January 2019
 

For immediate release

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

Pennant International Group plc

("Pennant", the "Company" or the "Group") 

 

Results of the Placing

 

Further to the accelerated bookbuilding process announced earlier today, Pennant International Group plc is pleased to announce the results of an oversubscribed placing with institutional investors of 2,281,110 Placing Shares, comprising 1,647,160 Fundraising Shares and 633,950 Available Option Shares. The Placing was conducted at a price of 110 pence per Placing Share. The Placing Price represents a discount of 3.93 per cent. to the closing price on 28 January 2019, the last trading day prior to this announcement.

 

The gross proceeds of the Fundraising amounting to £1.8 million (before expenses) together with the proceeds of the exercise of the 690,000 share options amounting to approximately £331,525 will predominantly be used to fund the potential Acquisition and to facilitate further new product development, as detailed in the Company's earlier announcement today. A further announcement will be made about the Acquisition in due course.

 

Application for admission to trading on AIM for 2,337,160 New Ordinary Shares (comprising 1,647,160 Fundraising Shares and 690,000 Option Shares) being issued pursuant to the Fundraising and the exercise of share options has been made and Admission is expected to take place on 1 February 2019. The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares in issue. The New Ordinary Shares will represent approximately 6.48 per cent. of the Enlarged Issued Share Capital on Admission (assuming no other issuance of ordinary shares prior to Admission).

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued share capital will comprise 36,040,693 Ordinary Shares of 5 pence each. All of these Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 36,040,693 on Admission.

 

Pennant's Chief Executive Officer, Phil Walker, said: "We are delighted by the support we have received for this fundraising which will enable us to accelerate our Group strategy of increasing both commercial and recurring revenues through the planned Acquisition and further investment in innovative new products."

 

Terms used in this Announcement shall have the meanings given to such terms in the definitions section of the appendix to the announcement made by the Company at 7.00 a.m. this morning.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Enquiries:

 

 

Pennant International Group plc

 

Simon Moore (Chairman)

+44 (0) 1452 714914

Philip Walker (Chief Executive Officer)

+44 (0) 1452 714914

 

 

WH Ireland Limited (Nominated Adviser and Broker)

 

Mike Coe / Chris Savidge (Corporate Finance)

+44 (0) 117 945 3470

Jasper Berry / Adam Pollock (Corporate Broking)

+44 (0) 207 220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0) 207 933 8780

+44 (0) 776 880 7631

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILKLFLKFFZBBX
Date   Source Headline
29th May 20125:48 pmRNSTransaction in Own Shares
25th May 201212:12 pmRNSTransaction in Own Shares
22nd May 201211:58 amRNSTransaction in Own Shares
15th May 201211:01 amRNSResult of AGM and GM
15th May 20127:00 amRNSTrading Statement
30th Apr 20125:12 pmRNSTransaction in Own Shares
5th Apr 20124:53 pmRNSDirector/PDMR Shareholding
2nd Apr 20122:55 pmRNSTransaction in Own Shares
2nd Apr 201210:46 amRNSPublication of Annual Report and Accounts/Circular
26th Mar 20127:00 amRNSFinal Results
10th Jan 201212:00 pmRNSTransaction in Own Shares
21st Dec 20111:28 pmRNSTransaction in Own Shares
21st Dec 20117:00 amRNSTrading Update
21st Oct 201111:53 amRNSTransaction in Own Shares
20th Sep 20112:31 pmRNSTransaction in Own Shares
15th Sep 20119:51 amRNSTreasury Stock
5th Sep 20117:00 amRNSHalf Yearly Report
17th May 201112:30 pmRNSAGM Statement
13th May 201110:32 amRNSTransaction in Own Shares
12th May 201112:49 pmRNSTransaction in Own Shares
6th May 20113:27 pmRNSTransaction in Own Shares
4th May 201112:55 pmRNSTransaction in Own Shares
28th Apr 20119:00 amRNSTransaction in Own Shares
21st Apr 201112:33 pmRNSTransaction in Own Shares
19th Apr 20111:37 pmRNSTransaction in Own Shares
13th Apr 201112:43 pmRNSPosting of Documents
30th Mar 201111:40 amRNSTransaction in Own Shares
28th Mar 20112:38 pmRNSTransaction in Own Shares
28th Mar 20117:00 amRNS2010 Final Results
22nd Mar 20117:00 amRNSRe Contract
4th Jan 20113:02 pmRNSChange of Registrars
8th Nov 201012:10 pmRNSDirectors incentivisation and Treasury Stock
5th Nov 20107:00 amRNSDirectorate Change
10th Sep 201012:24 pmRNSTransaction in Own Shares
9th Sep 20104:32 pmRNSHolding(s) in Company
6th Sep 20103:06 pmRNSTransaction in Own Shares
6th Sep 20107:00 amRNSHalf Yearly Report
14th Jul 201010:09 amRNSHolding(s) in Company
18th May 20101:01 pmRNSResult of AGM and GM
28th Apr 201011:10 amRNSHolding(s) in Company
13th Apr 20104:57 pmRNSPosting of Annual Report and Circular
29th Mar 20107:00 amRNSFinal Results
10th Mar 20107:00 amRNSSuccessful completion of Type 45 TMEC Warfare Pack
16th Feb 20107:00 amRNSNew Contract Award
11th Feb 201011:34 amRNSDividend Declaration (Replacement)
11th Feb 201010:32 amRNSDividend Declaration
11th Jan 20105:36 pmRNSTransaction in Own Shares
4th Jan 20102:25 pmRNSTransaction in Own Shares
17th Dec 200912:52 pmRNSDirector/PDMR Shareholding
1st Oct 200912:57 pmRNSIssue of Options and Option Amendments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.